Asaigermanium
Commercial- Indications
- Immune system modulation, Bone health, Pain management, Inflammation, Rheumatoid arthritis
Company intelligence / Profile preview
Asai Germanium Research Institute is the original developer and manufacturer of "Asaigermanium," the world's first organic germanium compound. The company has over 50 years of research supporting its safety and physiological effects, including immune enhancement, antiviral activity, bone metabolism regulation, pain reduction, and anti-inflammatory properties. Asaigermanium is used as an ingredient in health foods and cosmetics in Japan. Clinical studies have been conducted primarily for functional food/supplement applications rather than pharmaceutical drug approval.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asai Germanium Research Institute.